Trial Profile

POPULATION PHARMACOMETRICS FOR ASSESSING RISK OF BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAW (BRONJ)

Status: Withdrawn prior to enrolment

Phase of Trial: Phase IV

Latest Information Update: 14 Apr 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Zoledronic acid (Primary)
Indications Cancer
Focus Pharmacokinetics

Most Recent Events

09 Apr 2017 Planned initiation date changed from 1 Jan 2016 to 1 Jun 2016.
09 Apr 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.
26 Oct 2015 Planned End Date changed from 1 Jun 2020 to 1 Jun 2021, according to ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com